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Abstract
Male-factor infertility is responsible for 30-55% of all infertility cases. The causes of male infertility include 
varicocele, endocrine disorders, genital tract infections, genetic disorders and idiopathic. It is estimated that 
genetic abnormalities contribute to 50% of male infertility. In daily practice, the diagnosis of male infertility 
has been based on history taking, relevant physical examination, hormone tests and basic semen analysis 
with a strong emphasis on the assessment of sperm concentration, motility, and morphology. Although recent 
development in assisted-reproductive technologies such as in vitro fertilization and intrauterine insemination 
increases the chance of clinical pregnancy and live birth, genetic counseling and testing should always be 
performed whenever genetic risks are related to the cause of infertility for the identification of possible genetic 
abnormalities and to assess the risk of transmitting the genetic defects to future generations. Genetic defects 
affect male infertility by disrupting hormonal homeostasis, spermatogenesis, and sperm quality. These genetic 
defects include chromosomal abnormalities (e.g. Klinefelter Syndrome), Y chromosome deletions, and cystic 
fibrosis transmembrane conductance regulator gene mutations. The utilization of genetic counseling and 
testing is also important to predict the success of sperm retrieval in men with certain genetic abnormalities. To 
name a few, genetic analysis at the chromosomal level (karyotyping), androgen receptor gene mutations test, 
cystic fibrosis test, and Y chromosome microdeletions analysis should be considered in the diagnosis of male 
factor infertility where genetic risks are present.
Keywords:  male infertility; genetic disorders; genetic testing; genetic counseling; chromosomal abnormalities; 
karyotyping
Peran Pemeriksaan Genetik pada Infertilitas Laki-laki
Abstrak
Infertilitas yang disebabkan oleh faktor laki-laki sebanyak 30-55% dari semua kasus infertilitas. Penyebab 
infertilitas antara lain varikokel, kelainan endokrin, infeksi saluran kemih, kelainan genetik dan idiopatik. 
Kelainan genetik diperkirakan 50% dari seluruh kasus infertilitas laki-laki. Pada praktik sehari-hari, diagnosis 
infertilitas laki-laki didasarkan pada anamnesis, pemeriksaan fisik yang relevan, pemeriksaan hormon dan 
analisis sperma dasar yang diutamakan pada konsentrasi sperma, motilitas, dan morfologi. Perkembangan 
terkini teknologi reproduksi berbantukan seperti fertilisasi in vitro dan inseminasi intrauterin meningkatkan 
kemungkinan keberhasilan kehamilan dan memiliki anak, namun konseling dan pemeriksaan genetik 
harus selalu dikerjakan jika risiko genetik berhubungan dengan penyebab infertilitas. Tujuannya adalah 
untuk mengidentifikasi kemungkinan kelainan genetik dan menilai risiko defek genetik tersebut menurun ke 
generasi selanjutnya. Defek genetik mempengaruhi infertilitas laki-laki dengan merusak homeostasis hormon, 
spermatogenesis, dan kualitas sperma. Defek tersebut termasuk kelainan kromosom (Sindrom Klinefelter), 
delesi kromosom Y, dan mutasi gen fibrosis transmembrane conductance regulator. Pemanfaatan konseling 
dan pemeriksaan genetik juga penting dalam memprediksi tingkat kesuksesan pengambilan sperma pada 
laki-laki dengan kelainan genetik tertentu. Analisis genetik pada tingkat kromosom (karyotyping), pemeriksaan 
mutasi gen reseptor androgen, pemeriksaan cystic fibrosis, dan analisis mikrodelesi kromosom Y dapat 
dipertimbangkan dalam diagnosis infertilitas yang disebabkan oleh faktor laki-laki yang memiliki risiko genetik.
Kata kunci: infertilitas laki-laki; kelainan geneti; pemeriksaan genetik; konseling genetik; kelainan kromosom; 
karyotyping
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Introduction
Infertility is defined as the inability of a sexually 
active couple to conceive after 12 months of 
unprotected, regular intercourse.1 This condition 
affects approximately 15% of couples worldwide 
and involves both men and women factors.2 Male-
factor infertility is responsible for 30-50% of all 
infertility cases, either solely or in combination with 
female factors.3,4 Male infertility is caused by a wide 
variety of disorders include varicocele, endocrine 
disorders, genital tract infections, genetic disorders, 
and idiopathic origin.4
Azoospermia, the absence of spermatozoa 
in the ejaculate after at least two assessments of 
centrifuged semen, is found in 10-15% of all male 
infertility cases.5 Based on the patency of the 
sperm release pathway, azoospermia is divided 
into two categories: obstructive azoospermia (OA) 
and non-obstructive azoospermia (NOA).6 OA 
results from obstruction of the excurrent duct at any 
location between the rete testis and the ejaculatory 
duct. This condition contributes to 40% of all 
azoospermia cases.6 NOA is the most common 
form of azoospermia and it is caused by conditions 
other than hypothalamic-pituitary disease and 
obstruction of the male genital tract.7
Genetic disorders account for 15-30% of 
azoospermia,8 whereas idiopathic male infertility, 
in which there are normal findings on physical 
examination and endocrine, genetic and biochemical 
laboratory testing, is found in 12-41% of all 
azoospermia cases and it is likely that most of this case 
has underlying genetic causes.4 Common genetic 
disorders that may cause male infertility include 
chromosomal abnormalities (Klinefelter Syndrome/
KS, Robertsonian translocation), Y chromosome 
deletions, and cystic fibrosis transmembrane 
conductance regulator (CFTR) gene mutation.9
The invention of assisted reproductive 
technology (ART) has increased the chance of men 
with azoospermia to have offspring. Methods of 
sperm retrieval such as percutaneous epididymal 
sperm aspiration (PESA) and testicular sperm 
extraction (TESE) enables clinicians to retrieve 
sperms directly from the epididymis or the testicles 
of men with azoospermia to be used in in vitro 
fertilization (IVF) or intrauterine insemination 
(IUI). However, although the development of ART 
increases the chance of sperm retrieval among 
men with azoospermia, it does not prevent the 
transmission of genetic defects to the offspring. 
Children of men with Y chromosome deletions, 
for example, can inherit the defects as well as 
having an increased chance of having whole Y 
chromosome deletions.10 Therefore, in addition to 
the basic diagnostic strategy for male infertility, 
which often comprises of history taking, physical 
examination, endocrine testing, semen analysis, 
and imaging studies, further diagnostic investigation 
involving genetic counseling and testing is needed 
not only for diagnostic purpose, but also to make 
a prognosis of sperm retrieval result and to take 
necessary precautions to prevent the transmission 
of genetic defects to offspring.11
Genetic Abnormalities Related to Male Infertility
Genetic abnormalities associated with male 
infertility could be manifested in both OA and NOA 
phenotypes (Table 1). However, men with certain 
genetic defects can also produce sperm, although, 
with aneuploidies. The availability of IVF and IUI 
techniques increases the chance of transmitting 
this genetic defects to the future generations. 
Furthermore, children conceived via ART have an 
increased risk of having abnormal karyotype with 
approximately half of them are fathered by men 
with chromosomal abnormalities.9 In this paper, 
we mainly discuss three genetic defects that have 
pathological effects towards male fertility namely 
KS, Y chromosome deletions, and CFTR gene 
mutations. Chromosomal defects contribute as 
the most frequent genetic abnormalities affecting 
male infertility. It is detected in approximately 20% 
of men with abnormal semen parameters.12 The 
most common type of constitutional chromosome 
aberration among infertile men is represented by 
KS, while the most frequent structural chromosomal 
abnormality is Y chromosome microdeletions.13
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Table 1. Prevalence of Common Genetic Abnormalities Associated with MaleInfertility9
Genetic Abnormality Prevalence
Chromosomal Aberrations
Klinefelter syndrome 5-10% azoospermia; 2-5% severe oligozoospermia
Robertsonian translocations 0.5-1%
Reciprocal translocations 0.5-1%
Y Chromosome Deletions
AZFa 0.5-1%
AZFb 0.5-1%
AZFc 3-7%
AZFb+c 0.5-1%
Gene Mutations
CFTR 60-70% (5% in infertile men)
AR 2-3%
AZF = azoospermia factor, CFTR = cystic fibrosis transmembrane conductance regulator, AR = androgen receptor
Klinefelter Syndrome 
KS is the most common genetic cause of 
male hypogonadism. Approximately 1 in 600 
newborn males is affected by KS.14 The term 
KS originated from Harry F. Klinefelter, who in 
1942 described for the first time a clinical entity 
of men with gynecomastia, small testes, absent 
spermatogenesis, normal to moderate reduction 
of Leydig cell function and an increased level 
of FSH.15 KS is caused by a supernumerary X 
chromosome with 80% of men with KS are of the 
non-mosaic 47,XXY karyotype, while the other 
20% are of the 46,XY/47,XXY mosaicism.16 Ferlin 
et al9 reported that 76.6% of non-mosaic KS had 
complete azoospermia, while among the mosaic 
46,XY/47,XXY men, 74.4% were azoospermic. 
The prognosis of men with KS to father children 
before the introduction of IVF was not favourable. 
Now, however, men with KS have an increased 
chance of having children with the help of surgical 
sperm retrieval techniques.17 The sperm of KS men 
usually have a normal 23,X or 23,Y haploid genome 
and most of their children are chromosomally 
normal. However, an increased rate of autosomal 
and sex chromosome aneuploidies was reported 
in KS men’s offspring. This means there is a 
significant risk of these children to father their own 
offspring with 47,XXY or 47,XXX karyotype.18,19
Although the classical signs and symptoms 
of KS are recognized, many patients with KS only 
present with obscure phenotype. Therefore, the 
abnormality is underdiagnosed. It is estimated 
that only one-fourth of men with KS receive 
diagnoses.14 Consequently, with the development 
of advanced sperm retrieval techniques widely 
available nowadays, the rate of transmission of the 
disease towards future generations also increases. 
Boys with KS usually show some symptoms 
such as speech development delay, learning 
disabilities, or behavioral problems.20 Increased 
height velocity rate is usually notable between 
the age of 5 to 8, but differentiating between boys 
with KS and normal boys based on the physical 
appearance is difficult as the magnitude or timing 
of pubertal growth spurt does not differ significantly 
between boys with KS and normal boys.21 The 
abnormality is usually diagnosed after puberty, 
when men with KS start noticing small testicular 
size and symptoms of androgen deficiency with 
most of the patients diagnosed when they are 
unable to conceive and sperm analysis shows 
azoospermia.20 Early recognition of the signs and 
symptoms of KS, together with confirmation by 
karyotyping are of vital value in the diagnosis of KS. 
Y Chromosome Deletions
Y chromosome deletions are the second most 
common genetic abnormalities affecting male 
infertility after KS. It is estimated that the 
prevalence of Y chromosome deletions is around 
1:2000 to 1:3000 men.22,23 The azoospermia 
factor AZF located on the Y chromosome is divided 
into three regions: AZFa, AZFb, and AZFc based 
on their location from proximal to the distal of the 
chromosome.24 These regions contain genes that 
regulate germ cell development and involved in the 
pathophysiology of male infertility, i.e. azoospermia 
and severe oligozoospermia.25
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The incidence of Y chromosome microdeletions 
ranges from 1 to 55%.26,27 AZFc deletions 
contribute as the most common Y chromosome 
microdeletions (65-70%), followed by the AZFb, 
AZFb+c, or AZFa+b+c microdeletions (25-
30%). AZFa deletions are the rarest form of Y 
chromosome microdeletions, comprising of 5% of 
all Y chromosome microdeletions.28
AZFa deletions are associated with Sertoli 
cell-only syndrome (SCOS) and testicular 
histopathology shows complete germ cell loss and 
degeneration of seminiferous tubules. It is a result 
of non-allelic homologous recombination (NAHR) 
between repeated nearly identical DNA sequence.16
AZFb and AZFb+c deletions are also associated 
with SCOS or pre-meiotic spermatogenic arrest,17 
while AZFc deletion leads to azoospermia or severe 
oligozoospermia with different spermatogenic 
phenotypes in the testis. Sperm in the ejaculate 
or the testis is found in approximately 60% of men 
with AZFc deletions.9
The availability of sperm retrieval techniques 
to obtain sperm from men with Y chromosome 
microdeletions facilitates the transmission of genetic 
abnormalities to their children as male offspring of 
men with AZF deletions also carry the deletion and 
will have impaired spermatogenesis in adulthood.9 
Foresta et al29 reported in 2005 that men with 
AZF genes deletions had a significantly reduced 
percentage of normal Y-bearing spermatozoa 
compared to men with normozoospermia (p<0.01).
The identification of AZF deletions in men with 
azoospermia or severe oligozoospermia is 
important because it has a prognostic value towards 
sperm retrieval success. Men with AZFa and AZFb 
deletions have no chance of having any sperm in 
the testis, whereas there is a chance of obtaining 
viable sperm in men with AZFc deletions.30
CFTR Gene Mutations
Cystic fibrosis (CF) is an autosomal-recessive 
genetic disorder caused by mutations in CFTR 
gene, located on the long arm of chromosome 
7. It encodes a membrane protein that serves as 
an ion channel and regulates the formation of the 
ejaculatory duct, seminal vesicle, vas deferens 
and distal two-thirds of the epididymis. CFTR gene 
mutations are found in 5% of all infertile men and 
in 60-70% of OA, in particular among patients with 
congenital bilateral absence of the vas deferens 
(CBAVD), making them the most common genetic-
abnormality cause of OA.9
Other Examples of Genetic Abnormalities 
Affecting Male Fertility
Robertsonian and reciprocal translocations 
are common structural chromosomal abnormalities 
affecting male fertility. They contribute to 1% of all 
male infertility and usually show as azoospermia 
phenotype than oligozoospermia.4 Alteration of the 
gene expression pattern of the spermatozoa at many 
stages is found in Robertsonian translocations,31 
while impaired semen parameters or sperm 
aneuploidies are found among men with reciprocal 
translocations, although the exact mechanism is 
still not known.4 In addition to KS, other numerical 
chromosome abnormalities with variable fertility status 
can also occur, such as 47,XYY and 45,X/46,XY 
mosaicism.8Although phenotypically normal, men 
with 47,XYY karyotype may have spermatogenesis 
failure, maturation arrest, or SCOS.9
Androgens (testosterone and 5α-dihydrotestosterone/
DHT) are the hormones that regulate the development and 
maintenance of spermatogenesis.4 The androgen receptor 
(AR) is encoded by a gene located on the X chromo-
some and consequently, mutations in this gene cause 
a collection of defects known as androgen insensitivity 
syndrome (AIS). It is found in 2% of all infertile men 
and the majority of its patients may only have infertility 
as their sole symptoms.9
Genetic Counseling and Testing in Male Infertility
The diagnostic procedures to assess male 
infertility usually consist of history taking, physical 
examination, hormone levels, basic semen analysis, 
and relevant imaging studies. However, it is 
reported that routine semen analysis with emphasis 
on sperm concentration, motility, morphology alone 
is not enough in the diagnosis of male infertility.32 
In large centers, genetic counseling with genetic 
testing of male infertility using chromosomal 
analysis such as karyotyping, AR gene mutations 
test, CF test, and Y chromosome microdeletion 
analysis have been employed routinely.4
Genetic counseling involves a discussion of 
possible genetic conditions affecting male fertility 
and its importance in the routine assessment of male 
infertility. A successful genetic counseling comprises 
of relevant information exchange, presentation of 
choices related to the patient’s fertility status, and 
discussion of patient values and beliefs.30 Genetic 
counseling among couples, particularly regarding 
male infertility, is of paramount importance because, 
after successful conceptions genetic abnormalities, 
e.g. Y chromosome microdeletions, are also 
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transmitted to the male offspring. In most cases, 
father and the son share the same magnitude of 
genetic abnormalities. However, in certain cases, 
the offspring has larger genetic defects and the 
process will continue to future generations.33
According to the European Association of 
Urology (EAU), standard karyotype analysis 
must be performed to all men with a sperm 
concentration <10 million/mL who are seeking 
fertility treatment by IVF.34 Based on the American 
Urological Association (AUA), karyotyping and 
genetic counseling should be offered to all patients 
with NOA and severe oligozoospermia with sperm 
concentration <5 million/mL.35
Regarding Y chromosome microdeletions, the 
EAU stated that testing for microdeletions is not 
necessary in men with OA but should be offered 
to men with sperm concentration <5 million/mL 
for diagnostic and prognostic purpose. Men with 
complete AZFa or AZFb microdeletions are not 
advised to undergo sperm retrieval procedure as 
it is unlikely that any sperm will be found.34 The 
AUA, however, stated that although the prognosis 
for sperm retrieval is poor for patients with AZFa 
or AZFb deletions, the results of Y chromosome 
deletion analysis are not able to absolutely 
predict the absence of sperm.35 The EAU and 
AUA guidelines agree that in men with congenital 
bilateral absence of the vas deferens, both partners 
should be tested for CFTR gene mutations.34,35
Conclusion
The availability of sperm retrieval techniques 
to obtain sperm from men with azoospermia or 
severe oligozoospermia enables couples who 
previously had little chance of having children 
to conceive with the help of ART techniques. 
However, a large portion of these men have genetic 
abnormalities, which affect the spermatogenesis 
and if sperm is produced, increase the risk of 
transmitting the genetic abnormalities to future 
generations. Nowadays, genetic causes of male 
infertility have been recognized, whereas genetic 
counseling of infertile couples has markedly 
improved. Appropriate counseling based on the 
familial and reproductive history should be offered 
and certain genetic testing must be offered in 
routine assessment of male infertility, not only for 
diagnostic purpose but also to make a prognosis 
of sperm retrieval result and to take necessary 
precautions to prevent or manage the transmission 
of genetic defects to future generations.
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